$NEOS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Neos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Neos Therapeutics, Inc.. Get notifications about new insider transactions in Neos Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 15 2016 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Sell | S | 10.27 | 13,714 | 140,795 | 1,610,283 | 1.6 M to 1.6 M (-0.84 %) |
Apr 15 2016 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Sell | S | 10.16 | 12,375 | 125,754 | 1,623,997 | 1.6 M to 1.6 M (-0.76 %) |
Oct 19 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Payment of Exercise | F | 18.54 | 9,197 | 170,512 | 135,352 | 144.5 K to 135.4 K (-6.36 %) |
Oct 01 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | M | 0.32 | 410 | 131 | 0 | |
Oct 01 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Buy | M | 0.32 | 410 | 131 | 48,235 | 47.8 K to 48.2 K (+0.86 %) |
Oct 01 2015 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | P | 19.82 | 12,500 | 247,750 | 12,500 | |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | Engelking Dorothy | VP, Regulatory Affa ... | Option Exercise | A | 25.50 | 13,000 | 331,500 | 13,000 | |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | McDonnell Thomas P | Chief Commercial Of ... | Option Exercise | A | 25.50 | 43,586 | 1,111,443 | 43,586 | |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | Tengler Mark | Chief Technology Of ... | Option Exercise | A | 25.50 | 43,032 | 1,097,316 | 43,032 | |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 25.50 | 60,230 | 1,535,865 | 60,230 | |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 25.50 | 201,259 | 5,132,105 | 201,259 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Option Exercise | C | 0.00 | 1,348,655 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Option Exercise | C | 0.00 | 1,134,954 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Option Exercise | C | 0.00 | 432,523 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Buy | C | 0.00 | 561,938 | 0 | 1,215,052 | 653.1 K to 1.2 M (+86.04 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Buy | C | 0.00 | 472,897 | 0 | 653,114 | 180.2 K to 653.1 K (+262.40 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Kearny Venture Assoicates II L ... | 10% Owner | Buy | C | 0.00 | 180,217 | 0 | 180,217 | 0 to 180.2 K |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Tengler Mark | Chief Technology Of ... | Option Exercise | C | 0.00 | 6,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Tengler Mark | Chief Technology Of ... | Buy | C | 0.00 | 2,500 | 0 | 112,060 | 109.6 K to 112.1 K (+2.28 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | C | 0.00 | 840 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | X | 0.00 | 4,200 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | C | 0.00 | 20,890 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | C | 0.00 | 22,700 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | C | 0.00 | 8,650 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Buy | C | 0.00 | 350 | 0 | 47,825 | 47.5 K to 47.8 K (+0.74 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Buy | C | 0.00 | 8,703 | 0 | 47,475 | 38.8 K to 47.5 K (+22.45 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Buy | C | 0.00 | 9,458 | 0 | 38,772 | 29.3 K to 38.8 K (+32.26 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Buy | C | 0.00 | 3,604 | 0 | 29,314 | 25.7 K to 29.3 K (+14.02 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Option Exercise | C | 0.00 | 34,153 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Option Exercise | X | 0.00 | 170,766 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Option Exercise | C | 0.00 | 1,496,521 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Option Exercise | C | 0.00 | 493,982 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Option Exercise | C | 0.00 | 153,009 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Buy | C | 0.00 | 14,230 | 0 | 907,358 | 893.1 K to 907.4 K (+1.59 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Buy | C | 0.00 | 623,550 | 0 | 893,128 | 269.6 K to 893.1 K (+231.31 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Buy | C | 0.00 | 205,825 | 0 | 269,578 | 63.8 K to 269.6 K (+322.85 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | BLUHM ANDREW G | 10% Owner | Buy | C | 0.00 | 63,753 | 0 | 63,753 | 0 to 63.8 K |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 100,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 200,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 300,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 400,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 1,880,000 | 0 | 500,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 453,982 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Option Exercise | C | 0.00 | 173,009 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | P | 15.00 | 20,000 | 300,000 | 1,279,903 | 1.3 M to 1.3 M (+1.59 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 41,665 | 0 | 1,252,903 | 1.2 M to 1.3 M (+3.44 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 41,665 | 0 | 1,211,238 | 1.2 M to 1.2 M (+3.56 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 41,665 | 0 | 1,169,573 | 1.1 M to 1.2 M (+3.69 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 41,665 | 0 | 1,127,908 | 1.1 M to 1.1 M (+3.84 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 41,665 | 0 | 1,086,243 | 1 M to 1.1 M (+3.99 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 783,332 | 0 | 1,044,578 | 261.2 K to 1 M (+299.84 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 189,159 | 0 | 261,246 | 72.1 K to 261.2 K (+262.40 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | SCHULER JACK W | 10% Owner | Buy | C | 0.00 | 72,087 | 0 | 72,087 | 0 to 72.1 K |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 4,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 7,100 | 0 | 2,958 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | X | 0.00 | 20,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | X | 0.00 | 35,500 | 0 | 20,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 44,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 195,000 | 0 | 44,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 136,500 | 0 | 239,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 50,000 | 0 | 20,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 570,000 | 0 | 70,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 75,450 | 0 | 200,000 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Option Exercise | C | 0.00 | 927,397 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | P | 15.00 | 30,000 | 450,000 | 966,219 | 936.2 K to 966.2 K (+3.20 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 1,666 | 0 | 936,219 | 934.6 K to 936.2 K (+0.18 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 2,958 | 0 | 934,553 | 931.6 K to 934.6 K (+0.32 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 18,332 | 0 | 931,595 | 913.3 K to 931.6 K (+2.01 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 81,249 | 0 | 913,263 | 832 K to 913.3 K (+9.77 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 56,874 | 0 | 832,014 | 775.1 K to 832 K (+7.34 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 8,333 | 0 | 775,140 | 766.8 K to 775.1 K (+1.09 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 20,833 | 0 | 766,807 | 746 K to 766.8 K (+2.79 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 237,500 | 0 | 745,974 | 508.5 K to 746 K (+46.71 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 83,333 | 0 | 508,474 | 425.1 K to 508.5 K (+19.60 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 31,437 | 0 | 425,141 | 393.7 K to 425.1 K (+7.98 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Iannelli Ralph | 10% Owner | Buy | C | 0.00 | 386,415 | 0 | 393,704 | 7.3 K to 393.7 K (+5,301.34 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | C | 0.00 | 220,700 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | C | 0.00 | 240,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | M | 0.32 | 1,643 | 526 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | M | 2.31 | 28,897 | 66,752 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | X | 0.02 | 16,408 | 394 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | C | 0.00 | 91,956 | 0 | 369,888 | 277.9 K to 369.9 K (+33.09 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | C | 0.00 | 100,000 | 0 | 277,932 | 177.9 K to 277.9 K (+56.20 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | C | 0.00 | 20,833 | 0 | 177,932 | 157.1 K to 177.9 K (+13.26 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | M | 0.32 | 1,643 | 526 | 157,099 | 155.5 K to 157.1 K (+1.06 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | M | 2.31 | 28,897 | 66,752 | 155,456 | 126.6 K to 155.5 K (+22.83 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Buy | X | 0.02 | 16,408 | 394 | 126,559 | 110.2 K to 126.6 K (+14.90 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Engelking Dorothy | VP of Regulatory Af ... | Option Exercise | C | 0.00 | 1,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Engelking Dorothy | VP of Regulatory Af ... | Buy | C | 0.00 | 416 | 0 | 416 | 0 to 416 |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | President, CEO & Di ... | Option Exercise | C | 0.00 | 6,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | President, CEO & Di ... | Buy | C | 0.00 | 2,500 | 0 | 144,549 | 142 K to 144.5 K (+1.76 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 10,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | X | 0.00 | 10,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 41,700 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 390,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | X | 0.00 | 390,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,626,294 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Option Exercise | C | 0.00 | 975,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 4,166 | 0 | 1,278,328 | 1.3 M to 1.3 M (+0.33 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 17,374 | 0 | 1,274,162 | 1.3 M to 1.3 M (+1.38 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 10,416 | 0 | 1,256,788 | 1.2 M to 1.3 M (+0.84 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 162,500 | 0 | 1,246,372 | 1.1 M to 1.2 M (+14.99 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 677,622 | 0 | 1,083,872 | 406.3 K to 1.1 M (+166.80 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Presidio Partners 2007, L.P. | 10% Owner | Buy | C | 0.00 | 406,250 | 0 | 406,250 | 0 to 406.3 K |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Option Exercise | X | 0.00 | 104,166 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Option Exercise | X | 0.00 | 104,166 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 429,166 | 229.2 K to 429.2 K (+87.27 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 429,166 | 229.2 K to 429.2 K (+87.27 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Sell | S | 15.00 | 83,333 | 1,249,995 | 229,166 | 312.5 K to 229.2 K (-26.67 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Sell | S | 15.00 | 83,333 | 1,249,995 | 229,166 | 312.5 K to 229.2 K (-26.67 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | X | 12.00 | 104,166 | 1,249,992 | 312,499 | 208.3 K to 312.5 K (+50.00 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | X | 12.00 | 104,166 | 1,249,992 | 312,499 | 208.3 K to 312.5 K (+50.00 %) |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 208,333 | 0 | 208,333 | 0 to 208.3 K |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 208,333 | 0 | 208,333 | 0 to 208.3 K |
Jul 22 2015 | NEOS | Neos Therapeutics, ... | HELLER ALAN L | Director | Option Exercise | A | 15.00 | 12,500 | 187,500 | 41,397 | |
Jul 22 2015 | NEOS | Neos Therapeutics, ... | Fong Bryant | Director | Option Exercise | A | 15.00 | 12,500 | 187,500 | 12,500 | |
Jul 22 2015 | NEOS | Neos Therapeutics, ... | ROBITAILLE GREGORY J | Director | Option Exercise | A | 15.00 | 12,500 | 187,500 | 12,500 |